Exercise and Heart Failure
description
Transcript of Exercise and Heart Failure
Exercise and Heart FailureExercise and Heart Failure
Tami Ward MS, APRN, NP-C, CHFNOctober 10, 2013
I have no conflict of interest
ObjectivesObjectives
Discuss reduced ejection fraction(HFrEF) and preserved ejection fraction (HFpEF) heart failure
Examine the role and recommendations of exercise training in heart failure (HF)
Identify barriers and strategies to overcome these barriers in the HF population
Two Types of HF Two Types of HF
The definition of HF has now expanded to: a. HF with reduced ejection fraction
(HFrEF, EF≤40%) b. HF failure with preserved ejection fraction (HFpEF EF ≥50%) c. HFpEF, borderline (EF 41-49%) d. HFpEF, improved (EF >40%)
Definition of Heart FailureDefinition of Heart FailureClassification Ejection
FractionDescription
I. Heart Failure with Reduced Ejection Fraction (HFrEF)
≤40% Also referred to as systolic HF. Randomized clinical trials have mainly enrolled patients with HFrEF and it is only in these patients that efficacious therapies have been demonstrated to date.
II. Heart Failure with Preserved Ejection Fraction (HFpEF)
≥50% Also referred to as diastolic HF. Several different criteria have been used to further define HFpEF. The diagnosis of HFpEF is challenging because it is largely one of excluding other potential noncardiac causes of symptoms suggestive of HF. To date, efficacious therapies have not been identified.
a. HFpEF, Borderline 41% to 49% These patients fall into a borderline or intermediate group. Their characteristics, treatment patterns, and outcomes appear similar to those of patient with HFpEF.
b. HFpEF, Improved >40% It has been recognized that a subset of patients with HFpEF previously had HFrEF. These patients with improvement or recovery in EF may be clinically distinct from those with persistently preserved or reduced EF. Further research is needed to better characterize these patients.
ACCF/AHA 2013 HF Guidelines JAC 2013 5 June (E-Pub online)
Important points regarding HF Important points regarding HF managementmanagement
The number of patients with HF, as well as the cost to treat patients with HF, is expected to increase in the future.
All causes of HF must be evaluated, with consideration of multigenerational family histories and genetic testing.
Risk factors need to be continually addressed when managing a patient with HF: hypertension, lipid disorders, obesity, diabetes mellitus, tobacco use, and known cardiotoxic agents.
There is a clear mortality benefit from using guideline-directed medical therapy.
Important points regarding HF Important points regarding HF managementmanagement
Anticoagulation should not be used in patients with chronic HFrEF with no risk factors (atrial fibrillation, thromboembolic event, or cardioembolic source).
Aim for control of systolic and diastolic blood pressures, as well as volume status, to treat HFpEF.
Re-evaluate patients with left ventricular EF ≤35%, New York Heart Association class II-IV, left bundle branch block, and a QRS ≥150 ms for cardiac resynchronization therapy.
HF education, dietary restrictions, and exercise training should be provided for all patients to enhance self-care.
A HF multidisciplinary team, including a palliative care team, should be involved when treating patients with advanced HF.
Classification of Heart FailureClassification of Heart FailureACCF/AHA Stages of HF NYHA Functional Classification
A At high risk for HF but without structural heart disease or symptoms of HF.
None
B Structural heart disease but without signs or symptoms of HF.
I No limitation of physical activity. Ordinary physical activity does not cause symptoms of HF.
C Structural heart disease with prior or current symptoms of HF.
I No limitation of physical activity. Ordinary physical activity does not cause symptoms of HF.
II Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in symptoms of HF.
III Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms of HF.
IV Unable to carry on any physical activity without symptoms of HF, or symptoms of HF at rest.
D Refractory HF requiring specialized interventions.
ACCF/AHA 2013 HF Guidelines JAC 2013 5 June (E-Pub online)
STAGE AAt high risk for HF but without structural heart
disease or symptoms of HF
STAGE BStructural heart disease
but without signs or symptoms of HF
THERAPYGoals· Control symptoms· Improve HRQOL· Prevent hospitalization· Prevent mortality
Strategies· Identification of comorbidities
Treatment· Diuresis to relieve symptoms
of congestion· Follow guideline driven
indications for comorbidities, e.g., HTN, AF, CAD, DM
· Revascularization or valvular surgery as appropriate
STAGE CStructural heart disease
with prior or current symptoms of HF
THERAPYGoals· Control symptoms· Patient education· Prevent hospitalization· Prevent mortality
Drugs for routine use· Diuretics for fluid retention· ACEI or ARB· Beta blockers· Aldosterone antagonists
Drugs for use in selected patients· Hydralazine/isosorbide dinitrate· ACEI and ARB· Digoxin
In selected patients· CRT· ICD· Revascularization or valvular
surgery as appropriate
STAGE DRefractory HF
THERAPYGoals· Prevent HF symptoms· Prevent further cardiac
remodeling
Drugs· ACEI or ARB as
appropriate · Beta blockers as
appropriate
In selected patients· ICD· Revascularization or
valvular surgery as appropriate
e.g., Patients with:· Known structural heart disease and· HF signs and symptoms
HFpEF HFrEF
THERAPYGoals· Heart healthy lifestyle· Prevent vascular,
coronary disease· Prevent LV structural
abnormalities
Drugs· ACEI or ARB in
appropriate patients for vascular disease or DM
· Statins as appropriate
THERAPYGoals· Control symptoms· Improve HRQOL· Reduce hospital
readmissions· Establish patient’s end-
of-life goals
Options· Advanced care
measures· Heart transplant· Chronic inotropes· Temporary or permanent
MCS· Experimental surgery or
drugs· Palliative care and
hospice· ICD deactivation
Refractory symptoms of HF at rest, despite GDMT
At Risk for Heart Failure Heart Failure
e.g., Patients with:· Marked HF symptoms at
rest · Recurrent hospitalizations
despite GDMT
e.g., Patients with:· Previous MI· LV remodeling including
LVH and low EF· Asymptomatic valvular
disease
e.g., Patients with:· HTN· Atherosclerotic disease· DM· Obesity· Metabolic syndrome orPatients· Using cardiotoxins· With family history of
cardiomyopathy
Development of symptoms of HF
Structural heart disease
ACCF/AHA 2013 HF Guidelines JAC 2013 5 June (E-Pub online)
Signs and Symptoms in HF Signs and Symptoms in HF patientspatients
Exercise intolerance due to fatigue and dyspnea most prominent
Other S & S:◦Paroxysmal nocturnal dyspnea◦Orthopnea, ◦Edema◦Worsening dyspnea with exertion or at rest◦Tachycardia◦Change in weight
Role of Exercise Training in HFRole of Exercise Training in HF
Current Guidelines 2013:◦Class I Exercise training (or regular physical activity) is
recommended as safe and effective for patients with HF who are able to participate to improve functional status
(Level of Evidence: A)
◦Class IIa Cardiac rehabilitation can be useful in clinically
stable patients with HF to improve functional capacity, exercise duration, HRQOL, and mortality.
(Level of Evidence: B)
Benefits with exercise and cardiac Benefits with exercise and cardiac rehabilitationrehabilitation
Improvement in exercise capacity after exercise training due to peripheral adaptations (increased oxygen extraction)
Improvement in quality of lifeReduced hospitalizations and mortalityImproved endothelial functionReduction in catecholamine levels
Risks to exerciseRisks to exercise
Three major risk factors: age, presence of heart disease and intensity of exercise◦Lowest incidence: walking, cycling and treadmill walking
◦Least active patients are higher risk◦In HF patients, most common events include: post-exercise hypotension, atrial and ventricular arrhythmias and worsening HF symptoms
Relative Contraindications to Relative Contraindications to Exercise in Stable HF PatientsExercise in Stable HF Patients
Weight gain > 3 lb in 1-3 daysDrop in systolic BP with exercise
(marked/symptomatic)NYHA IV (can exercise selective patients)Complex ventricular arrhythmias Resting heart rate ≥ 100 bpmPre-existing unstable co-morbidities
Absolute Contraindications to Absolute Contraindications to Exercise with Stable HF Exercise with Stable HF PatientsPatients
Progressive worsening of exercise intolerance (dyspnea at rest)
Ischemia is suspectedSevere AS or severe regurgitant
valvular diseaseAcute systemic illnessNew onset afibAcute pericarditis/myocarditis/embolism
Exercise RecommendationsExercise Recommendations
Aerobic activity such as walking or cycling
Frequency – 3-5 days a week or most days
Intensity – 55-80% heart rate reserve with perceived exertion (11-14)
Duration of each session – start at 5 minutes if needed and progress to 30-60 minutes
Exercise RecommendationsExercise Recommendations
Cycling◦Allows low level workloads◦Easily reproducible◦May be safer with orthopedic or balance problems
WalkingSwimmingyogaInterval trainingFlexibility and resistance training
Barriers and possible Barriers and possible solutionssolutions
Patient relatedSocial and economicHealthcare team/systemCondition and Therapy related
Patient related BarriersPatient related Barriers
Older ageLow level of educationLow socio-economic statusMinority statusAnxiety and depressionLogistical problemsLack of motivation, lack of insight into
benefits and lack of time
European Journal of Heart Failure (2012) 14, 451-458
Social and Economic BarriersSocial and Economic Barriers
Lack or resources and supportLack of reimbursementTransportation concerns
European Journal of Heart Failure (2012) 14, 451-458
Healthcare team/system barriersHealthcare team/system barriers
Lack of expertise with heart failureLack of capacityLack of referralLack of education on the importance of
exercise
European Journal of Heart Failure (2012) 14, 451-458
Condition and Therapy Related Condition and Therapy Related BarriersBarriers
Severity of symptomsLevel of disabilityRate of disease progressionImpact of co-morbidities
European Journal of Heart Failure (2012) 14, 451-458
Recommendations to overcome Recommendations to overcome barriersbarriers
Patient related◦Optimize heart failure management; manage
co-morbid conditions ◦Discuss activity at each visit to rehab◦Assess preferred mode of exercise◦Education; engage patient as partner in
exercise◦Screen for depression
Recommendations to overcome Recommendations to overcome barriersbarriers
System and therapy related◦Have referral system in place◦Educate providers
Case studyCase study
74 year-old male with history of coronary artery disease; inferior STEMI 2010 (unsuccessful PCI)complicated with cardiogenic shock and VT; initial EF 25%; received single chamber ICD
◦Hypertension◦Hyperlipidemia◦Osteoarthritis◦ Ischemic cardiomyopathy◦insomnia
Case StudyCase Study
Social History◦Never used tobacco products◦No alcohol and substance abuse◦Retired lawyer
Family History◦Father died of sudden death – age 60
Surgical History◦Cataracts; ICD implant
Case studyCase study
Medications◦Aspirin 81mg daily◦Carvedilol 12.5mg twice daily◦Lisinopril 20mg daily (now on study drug – NEP
inhibitor)◦Furosemide 40mg twice daily◦Potassium 20mEq daily◦Simvastatin 40mg daily◦Meloxicam as needed◦Trazadone 25mg at bedtime◦Nitroglycerine 0.4mg as needed
Case StudyCase StudyExercise history
◦Swimmer in high school◦Lifeguard at the Officers Club Pool in the Army
Medical Core◦Cardiac rehab after STEMI◦Resumed swimming after MI U.S. Master’s Senior Olympics
9 Gold medals in Kansas Senior Meet - September ‘13
“My Doctor said if I hadn’t been in such good physical shape from swimming it very likely would have been a fatal heart attack. Swimming or any kind of exercise saves lives”.
In SummaryIn Summary
Find strategies to get patients referred and enrolled in your cardiac rehabilitation program
Use this opportunity to give disease specific education to the HF patients
Prescribing exercise for HF patients is similar to patients without HF
Partner with your providers to help keep these patients out of the hospital with close surveillance of their symptoms.
[email protected]@Alegent.org
Thank You!